Oxford Sciences Innovation has returned to back a $30m funding round for Genomics, having previously contributed to a 2018 series B round.
Genomics, a UK-based precision healthcare spinout of University of Oxford, closed a $30m funding round yesterday backed by university venture fund Oxford Sciences Innovation (OSI).
Foresite Capital and F-Prime Capital, an investment affiliate of financial services group Fidelity, and Lansdowne Partners also participated in the round.
Founded in 2014, Genomics has developed a machine learning-powered genomic analytics platform that determines the risk of individuals for common diseases before they manifest.
Apart from delivering its population health management…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
